毕得医药部分股东拟合计减持不超1%股份

Core Viewpoint - Bid Pharma (688073.SH) announced that shareholders plan to reduce their holdings due to personal liquidity needs, with a maximum reduction of 1% of the company's total share capital within three months after the disclosure of the reduction plan [1] Group 1 - Shareholders involved in the reduction include Li Yijing, Chen Jun, Li Li, Du Juan, Li Aifei, Geng Yong, and Jiang Yaomei [1] - The reduction will be executed through centralized bidding based on market conditions [1] - The reduction period starts three trading days after the announcement [1]